Ljubljana Clinical Neurophysiology Symposium 2023

Regional ALS Meeting

Friday, 29 September

11:10-11:15	Opening
11:15-12:00	39th Dr Janez Faganel Memorial Lecture
	Biomarker development in ALS: From muscle to brain to blood
	Martin Turner
12:00-13:00	Roche Satellite Symposium
	Experience with the oral drug Evrysdi in adult patients with SMA in Slovenia
	Blaž Koritnik
13:00-14:00	Medison Satellite Symposium
	Myasthenia gravis – A look forward
	Efgartigimod: The significance of a new treatment option for generalized myasthenia gravis
	Filippo Rocca
	Challenges, limitations, and new opportunities for patients with generalized myasthenia gravis
	Mateja Baruca Grad
14:00-16:00	Symposium I
	Update on genetics of ALS
	David Brenner
	Treatment of ALS patients with SOD1 mutations with tofersen - first results from the German Early Access Program
	Maximilian Wiesenfarth & Zeynep Elmas
	The effect of nutrition on prognosis of ALS - insights from clinical studies
	Johannes Dorst
	Ketogentic diet in ALS - a potential treatment option?
	Christine Herrmann
	Cognition in ALS - a transnational evaluation of the ECAS
	Dorothée Lulé
16:00-16:30	Coffee Break
16:30-18:30	Symposium II
	Novel approaches for gene hunting in ALS
	Ahmad Al Khleifat
	Epigenetic sex differences in ALS
	Olivia Grant
	Big data approaches for drug target validation in ALS
	Alfredo Iacoangeli
	Modelling and drug screening in ALS
	Jackie Mitchell
20:30-23:00	Dinner at the Ljubljana Castle

Saturday, 30 September

9:00-11:00	Symposium III
	Integrative analyses of ALS patient tissue reveal pathogenic aberrant splicing events and hidden genetic risk factors
	Kevin Kenna
	MCH neurons in ALS: vulnerability and connectivity
	Jelena Scekic-Zahirovic
	The role of Sirt1 in C9ORF72-related ALS-FTD
	Hakan Cetin
	Protein homeostasis in C9orf72
	Boris Rogelj
	Circular RNAs as potential peripheral blood biomarkers for amyotrophic lateral sclerosis
	Metka Ravnik Glavač
12:00-13:00	Genesis Pharma Satellite Symposium
	The evolving treatment landscape in ATTRv Amyloidosis
	Diagnostic challenges and importance of early intervention in ATTRv amyloidosis
	Janez Zidar
	Optimising management of ATTRv amyloidosis in clinical practice – from patisiran to vutrisiran
	Elena Zamba-Papanicolaou
13:00-14:00	Novartis Satellite Symposium
	Analysis of brain MRI images using artificial intelligence technologies
	Žiga Špiclin
14:00-16:00	Symposium IV
	Genetics of ALS: a population-based study in Serbia
	Aleksa Palibrk
	ALS clinical practice in Croatia: current situation and future perspectives
	Hrvoje Bilić
	Three years of the home care ALS programme in Slovenia
	Janez Zidar
	Social cognition impairment in ALS
	Sara Kadenšek
	Gastrostomy and survival in ALS – benefits and risks
	Blaž Koritnik